| 1 |
Loutherback K, Dietz AB. Capture and reagent exchange (CARE) wells for cell isolation, labeling, and characterization. Microfluid Nanofluid 2022;26. [DOI: 10.1007/s10404-022-02568-6] [Reference Citation Analysis]
|
| 2 |
Vieira CP, McCarrel TM, Grant MB. Novel Methods to Mobilize, Isolate, and Expand Mesenchymal Stem Cells. Int J Mol Sci 2021;22:5728. [PMID: 34072061 DOI: 10.3390/ijms22115728] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Nath SC, Harper L, Rancourt DE. Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance. Front Bioeng Biotechnol 2020;8:599674. [PMID: 33324625 DOI: 10.3389/fbioe.2020.599674] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 4 |
Scheer V, Goldammer M, Flindt S, van Zandbergen G, Hinz T. Therapeutische Immunisierungen gegen Tumore und neurodegenerative Erkrankungen. Bundesgesundheitsbl 2020;63:1373-1379. [DOI: 10.1007/s00103-020-03226-4] [Reference Citation Analysis]
|
| 5 |
Cunningham S, Hackstein H. Recent Advances in Good Manufacturing Practice-Grade Generation of Dendritic Cells. Transfus Med Hemother 2020;47:454-63. [PMID: 33442340 DOI: 10.1159/000512451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Mfarrej B, Gaude J, Couquiaud J, Calmels B, Chabannon C, Lemarie C. Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products. Cytotherapy 2021;23:77-87. [PMID: 32718876 DOI: 10.1016/j.jcyt.2020.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Moreira A, Erdmann M, Uslu U, Vass V, Schuler G, Schuler-Thurner B. Blood Eosinophilia is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA. Pharmaceutics 2020;12:E210. [PMID: 32121531 DOI: 10.3390/pharmaceutics12030210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 8 |
Boudousquié C, Boand V, Lingre E, Dutoit L, Balint K, Danilo M, Harari A, Gannon PO, Kandalaft LE. Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine. Vaccines (Basel) 2020;8:E25. [PMID: 31947581 DOI: 10.3390/vaccines8010025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 9 |
Uslu U, Erdmann M, Wiesinger M, Schuler G, Schuler-thurner B. Automated Good Manufacturing Practice–compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines. Cytotherapy 2019;21:1166-78. [DOI: 10.1016/j.jcyt.2019.09.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 10 |
Bialek-Waldmann JK, Heuser M, Ganser A, Stripecke R. Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation. Cancer Immunol Immunother 2019;68:1891-9. [PMID: 31628525 DOI: 10.1007/s00262-019-02406-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Marín Morales JM, Münch N, Peter K, Freund D, Oelschlägel U, Hölig K, Böhm T, Flach AC, Keßler J, Bonifacio E, Bornhäuser M, Fuchs A. Automated Clinical Grade Expansion of Regulatory T Cells in a Fully Closed System. Front Immunol 2019;10:38. [PMID: 30778344 DOI: 10.3389/fimmu.2019.00038] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
|
